logo

For the Inventor, By the Inventor

Cinisello Balsamo, Italy

Flavio Leoni

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 100(Granted Patents)


Location History:

  • Giovanni, IT (1998)
  • Sesto S. Giovanni, IT (1996 - 2000)
  • Cinisello Balsamo, IT (1999 - 2007)
  • Milan, IT (2012)

Company Filing History:

goldMedal10 out of 48 
 
Italfarmaco Spa
 patents

Years Active: 1996-2012

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 8227515 - Use of hydroxamic acid derivatives for the preparation of anti-tumour medicaments (2012-07-24),
2. 7157099 - Sustained release pharmaceutical compositions for the parenteral administration of hydrophilic compounds (2007-01-02),
3. 6342481 - Oligopeptides derived from C-reactive protein fragments (2002-01-29),
4. 6130210 - Heparin derivatives having antimetastatic activity (2000-10-10),
5. 6057295 - Oligopeptides derived from C-reactive protein fragments (2000-05-02),
6. 6034096 - Compounds with anti-inflammatory and immunosuppressive activities (2000-03-07),
7. 5905090 - Analogues of the active metabolite of leflunomide (1999-05-18),
8. 5763421 - Heparin derivatives having antimetastatic activity (1998-06-09),
9. 5578575 - Partially modified and retro-inverted tetrapeptides analogues of (1996-11-26),
10. 5521159 - Partially modified and retro-inverted tetrapeptides analogues of (1996-05-28),

Title: Flavio Leoni: Innovator in Pharmaceutical Science

Introduction

Flavio Leoni is a prominent inventor based in Cinisello Balsamo, Italy. He has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative medicaments. With a total of 10 patents to his name, Leoni's work focuses on advancing treatments for various medical conditions.

Latest Patents

Among his latest patents is the "Use of hydroxamic acid derivatives for the preparation of anti-tumour medicaments." This patent details a method of treating tumors in patients by administering an effective amount of a specific compound, 4-[6-(diethylaminomethyl)naphth-2-ylmethyloxycarbamoyl]benzohydrozamic acid. Another notable patent is for "Sustained release pharmaceutical compositions for the parenteral administration of hydrophilic compounds." This invention involves stable, biologically compatible pharmaceutical compositions in the form of water-in-oil microemulsions, designed for the sustained release of active ingredients that are hydrophilic or made hydrophilic through suitable derivatization.

Career Highlights

Flavio Leoni is currently associated with Italfarmaco Spa, a company known for its commitment to research and development in the pharmaceutical sector. His work at Italfarmaco has allowed him to focus on creating innovative solutions that address critical health challenges.

Collaborations

Leoni collaborates with esteemed colleagues such as Paolo Mascagni and Patrizia Caretto. Their combined expertise contributes to the advancement of pharmaceutical innovations and enhances the impact of their research.

Conclusion

Flavio Leoni's contributions to pharmaceutical science through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for new treatments that can significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…